Vireo Growth (VREOF) EPS (Basic) (2020 - 2026)
Vireo Growth (VREOF) posted EPS (Basic) of -$0.02 for Q1 2026, up 54.7% sequentially from -$0.05 in Q4 2025, and down 257.18% YoY from $0.01 in Q1 2025.
Vireo Growth (VREOF) EPS (Basic) (2020 - 2026) Analysis & Trends
Vireo Growth has reported EPS (Basic) for 7 years, with the latest figure at -$0.02 in Q1 2026.
- Quarterly EPS (Basic) fell 257.18% year-over-year to -$0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.05 (down 196.59% YoY) and the FY2025 annual result came in at -$0.11, down 222.35% from the prior year.
- EPS (Basic) advanced to -$0.02 in Q1 2026 per VREOF's latest filing, from -$0.05 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.03 in Q2 2024 and troughed at -$0.14 in Q1 2022.
- A 5-year average of -$0.02 and a median of -$0.02 in 2026 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 153.84% in 2024, then tumbled 297.17% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.07 in 2022, then jumped by 136.42% to $0.03 in 2023, then dropped by 11.71% to $0.02 in 2024, then sank by 297.17% to -$0.05 in 2025, then soared by 54.7% to -$0.02 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.02, -$0.05, and $0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Vireo Growth | 494.14 Mn | 351.84 Mn | 95.30 Mn | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02 |
| Dec 31, 2025 | -0.05 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.06 |
| Mar 31, 2023 | -0.07 |
| Dec 31, 2022 | -0.07 |
| Sep 30, 2022 | -0.07 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -0.14 |
| Dec 31, 2021 | -0.11 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.06 |